Catalyst Wire Dossier Catalyst Wire Dossier

XEN801 Topical Gel

XEN801 · Xenon Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XEN801 Topical Gel, covering 2019-01-22 to 2019-01-22. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel [Phase 1, Phase 2]

See pricing